<?xml version="1.0" encoding="UTF-8"?>
<ref id="B176">
 <label>176.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Jokinen</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Tretyakova</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Pushko</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Lukashevich</surname>
    <given-names>IS</given-names>
   </name>
  </person-group>. 
  <article-title>Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins</article-title>. 
  <source>Vaccine</source> (
  <year>2018</year>) 
  <volume>36</volume>:
  <fpage>683</fpage>â€“
  <lpage>90</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.12.046</pub-id>
  <?supplied-pmid 29287681?>
  <pub-id pub-id-type="pmid">29287681</pub-id>
 </mixed-citation>
</ref>
